Patents by Inventor Clark Allphin

Clark Allphin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GHB FORMULATION AND METHOD FOR ITS MANUFACTURE
    Publication number: 20240016770
    Abstract: The present application relates to GHB formulations and methods for manufacturing the same.
    Type: Application
    Filed: September 25, 2023
    Publication date: January 18, 2024
    Inventors: Clark ALLPHIN, Scott BURA
  • GHB formulation and method for its manufacture
    Patent number: 11364215
    Abstract: The present application relates to GHB formulations and methods for manufacturing the same.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: June 21, 2022
    Assignee: JAZZ PHARMACEUTICALS IRELAND LIMITED
    Inventors: Clark Allphin, Scott Bura
  • DEVICES AND METHODS FOR FACILITATING AND CONTROLLING USE OF A MEDICATION
    Publication number: 20220096430
    Abstract: A device includes a reservoir configured to store a drug formulation including at least one abuse-preventing additive. The device further includes means configured to remove the at least one abuse-preventing additive. The device further includes means configured to prevent access to the drug formulation.
    Type: Application
    Filed: May 13, 2021
    Publication date: March 31, 2022
    Inventor: Clark ALLPHIN
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20220096384
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: December 13, 2021
    Publication date: March 31, 2022
    Inventors: Clark ALLPHIN, James PFEIFFER
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 11207270
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: December 28, 2021
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20210346300
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: July 20, 2021
    Publication date: November 11, 2021
    Inventors: Clark ALLPHIN, James PFEIFFER
  • GHB formulation and method for its manufacture
    Patent number: 11147782
    Abstract: The present application relates to GHB formulations and methods for manufacturing the same.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: October 19, 2021
    Assignee: JAZZ PHARMACEUTICALS IRELAND LIMITED
    Inventors: Clark Allphin, Scott Bura
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 11090269
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: August 17, 2021
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20210244670
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: April 7, 2021
    Publication date: August 12, 2021
    Inventors: Clark ALLPHIN, James PFEIFFER
  • GHB formulation and method for its manufacture
    Patent number: 11077079
    Abstract: The present application relates to GHB formulations and methods for manufacturing the same.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: August 3, 2021
    Assignee: Jazz Pharmaceuticals Ireland Limited
    Inventors: Clark Allphin, Scott Bura
  • Devices and methods for facilitating and controlling use of a medication
    Patent number: 11033530
    Abstract: A device includes a reservoir configured to store a drug formulation including at least one abuse-preventing additive. The device further includes means configured to remove the at least one abuse-preventing additive. The device further includes means configured to prevent access to the drug formulation.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: June 15, 2021
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventor: Clark Allphin
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 10987310
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: April 27, 2021
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 10966931
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: April 6, 2021
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 10959956
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: March 30, 2021
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20200397705
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: September 4, 2020
    Publication date: December 24, 2020
    Inventors: Clark ALLPHIN, James PFEIFFER
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20200397706
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: September 4, 2020
    Publication date: December 24, 2020
    Inventors: Clark ALLPHIN, James PFEIFFER
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 10813885
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: October 27, 2020
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20200330389
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 22, 2020
    Inventors: Clark ALLPHIN, James PFEIFFER
  • Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
    Patent number: 10758488
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: September 1, 2020
    Assignee: JAZZ PHARMACEUTICALS, INC.
    Inventors: Clark Allphin, James Pfeiffer
  • CONTROLLED RELEASE DOSAGE FORMS FOR HIGH DOSE, WATER SOLUBLE AND HYGROSCOPIC DRUG SUBSTANCES
    Publication number: 20200113840
    Abstract: Controlled release dosage forms are described herein. The controlled release formulations described herein provide prolonged delivery of high dose drugs that are highly water soluble and highly hygroscopic. In specific embodiments, controlled release dosage forms for delivery of a drug selected from GHB and pharmaceutically acceptable salts, hydrates, tautomers, solvates and complexes of GHB. The controlled release dosage forms described herein may incorporate both controlled release and immediate release formulations in a single unit dosage form.
    Type: Application
    Filed: December 12, 2019
    Publication date: April 16, 2020
    Inventors: Clark ALLPHIN, James PFEIFFER